KNSA vs. BMRN
Compare and contrast key facts about Kiniksa Pharmaceuticals, Ltd. (KNSA) and BioMarin Pharmaceutical Inc. (BMRN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KNSA or BMRN.
Performance
KNSA vs. BMRN - Performance Comparison
Returns By Period
In the year-to-date period, KNSA achieves a 22.58% return, which is significantly higher than BMRN's -35.77% return.
KNSA
22.58%
-18.13%
9.30%
36.86%
19.28%
N/A
BMRN
-35.77%
-11.67%
-19.62%
-29.24%
-4.38%
-3.22%
Fundamentals
| KNSA | BMRN | |
|---|---|---|
| Market Cap | $1.66B | $12.60B |
| EPS | -$0.12 | $1.66 |
| Total Revenue (TTM) | $384.10M | $735.87B |
| Gross Profit (TTM) | $233.93M | $546.99B |
| EBITDA (TTM) | -$24.71M | $114.17B |
Key characteristics
| KNSA | BMRN | |
|---|---|---|
| Sharpe Ratio | 0.84 | -0.93 |
| Sortino Ratio | 1.50 | -1.11 |
| Omega Ratio | 1.19 | 0.82 |
| Calmar Ratio | 0.79 | -0.50 |
| Martin Ratio | 3.84 | -1.66 |
| Ulcer Index | 10.08% | 17.44% |
| Daily Std Dev | 46.11% | 31.12% |
| Max Drawdown | -83.06% | -90.58% |
| Current Drawdown | -30.49% | -58.47% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between KNSA and BMRN is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
KNSA vs. BMRN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Kiniksa Pharmaceuticals, Ltd. (KNSA) and BioMarin Pharmaceutical Inc. (BMRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
KNSA vs. BMRN - Dividend Comparison
Neither KNSA nor BMRN has paid dividends to shareholders.
Drawdowns
KNSA vs. BMRN - Drawdown Comparison
The maximum KNSA drawdown since its inception was -83.06%, smaller than the maximum BMRN drawdown of -90.58%. Use the drawdown chart below to compare losses from any high point for KNSA and BMRN. For additional features, visit the drawdowns tool.
Volatility
KNSA vs. BMRN - Volatility Comparison
Kiniksa Pharmaceuticals, Ltd. (KNSA) has a higher volatility of 19.57% compared to BioMarin Pharmaceutical Inc. (BMRN) at 6.79%. This indicates that KNSA's price experiences larger fluctuations and is considered to be riskier than BMRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
KNSA vs. BMRN - Financials Comparison
This section allows you to compare key financial metrics between Kiniksa Pharmaceuticals, Ltd. and BioMarin Pharmaceutical Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities